All AstraZeneca articles – Page 4
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Business
AstraZeneca to close environmental lab and cut 71 jobs
Environmental impact services will be outsourced after Devon lab closes in March 2014
-
BusinessNew respiratory drugs neck and neck
Combination inhalers from GSK and Novartis approved in EU and Japan
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
BusinessAstraZeneca announces new UK hub
Restructuring will see all AstraZeneca R&D at new location close to University of Cambridge research
-
Business
AstraZeneca site to become biotech hub
As AZ leaves, Alderley Park will become an incubator for small companies
-
Business
AstraZeneca partners with Moderna for $240 million
Pharma company sheds more jobs and backs messenger RNA therapeutics
-
BusinessGlobal AstraZeneca restructuring will cost 1600 jobs
Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Business
EU companies increasing R&D
Difficult economic climate has not diminished EU enthusiasm for R&D
-
Business
Patent woes lead to sharp sales losses
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
-
Business
Pfizer to pay $250m for Nexium
AstraZeneca has sold rights to an over the counter version of its heartburn tablets
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
-
News€224 million EU antibiotics initiative launched
The project will bring together the pharmaceutical industry and academia, but some institutes have reservations
-
BusinessAstraZeneca seeks to refill dry pipeline with gout drug
UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page